Jennifer Crozier
Hematology & Oncology · Jacksonville, FLNPI 1992017735
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Novartis accounts for 67.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $29,289 and has fallen 99.1% since, to $278 in 2023.
Across 60 payments — averaging $909.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$37K
- Pfizer$6K
- Gilead$6K
- AstraZeneca$2K
- Daiichi Sankyo Inc.$2K
- Seagen Inc.$2K
- plus $807 from 2 others
Across 453 payments — averaging $7670.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$1.4M
- Seagen Inc.$949K
- Novartis$504K
- Roche Products Limited$416K
- Daiichi Sankyo Inc.$106K
- Hoffmann-la Roche Limited$32K
- plus $45K from 3 others
What the payments were for
- Consulting fees$23,74844%
- Speaking & faculty fees$20,85038%
- Travel & lodging$8,81516%
- Food & beverage$1,0782%
- Education$730%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 34 | $37,022 |
| Pfizer | 3 | $5,617 |
| Gilead | 9 | $5,566 |
| AstraZeneca | 3 | $1,965 |
| Daiichi Sankyo Inc. | 2 | $1,938 |
| Seagen Inc. | 1 | $1,650 |
| Merck | 7 | $746 |
| Tesaro, Inc. | 1 | $61 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$54,564 in reported general payments places this provider in the 85th percentile of 694 hematology & oncology providers in Florida.
Other hematology & oncology in Jacksonville
- Edith PerezJacksonville$1.1M
- Vamsidhar VelchetiJacksonville$966K
- Arnab BasuJacksonville$440K
- Sikander AilawadhiJacksonville$179K
- James ForanJacksonville$164K
- Asher Chanan KhanJacksonville$109K
- Martin DietrichRockledge$6.2M
- Mark SocinskiOrlando$2.4M
- Tarek MekhailOrlando$2.2M
- Edgardo SantosFort Lauderdale$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.